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Abstract
Background: To understand user needs, system requirements and organizational conditions towards successful
design and adoption of Clinical Decision Support Systems for Type 2 Diabetes (T2D) care built on top of
computerized risk models.
Methods: The holistic and evidence-based CEHRES Roadmap, used to create eHealth solutions through participatory
development approach, persuasive design techniques and business modelling, was adopted in the MOSAIC project to
define the sequence of multidisciplinary methods organized in three phases, user needs, implementation and evaluation.
The research was qualitative, the total number of participants was ninety, about five-seventeen involved in each round
of experiment.
Results: Prediction models for the onset of T2D are built on clinical studies, while for T2D care are derived from
healthcare registries. Accordingly, two set of DSSs were defined: the first, T2D Screening, introduces a novel routine; in
the second case, T2D Care, DSSs can support managers at population level, and daily practitioners at individual level. In
the user needs phase, T2D Screening and solution T2D Care at population level share similar priorities, as both deal with
risk-stratification. End-users of T2D Screening and solution T2D Care at individual level prioritize easiness of use and
satisfaction, while managers prefer the tools to be available every time and everywhere. In the implementation phase,
three Use Cases were defined for T2D Screening, adapting the tool to different settings and granularity of information.
Two Use Cases were defined around solutions T2D Care at population and T2D Care at individual, to be used in primary
or secondary care. Suitable filtering options were equipped with “attractive” visual analytics to focus the attention of
end-users on specific parameters and events. In the evaluation phase, good levels of user experience versus bad level of
usability suggest that end-users of T2D Screening perceived the potential, but they are worried about complexity.
Usability and user experience were above acceptable thresholds for T2D Care at population and T2D Care at individual.
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Conclusions: By using a holistic approach, we have been able to understand user needs, behaviours and interactions
and give new insights in the definition of effective Decision Support Systems to deal with the complexity of T2D care.
Keywords: Type 2 diabetes, Computerized decision support systems, Risk modelling, Human centred design, Multi-
disciplinary approach
Background
Most of the problems related to older age are linked to
chronic diseases [1]. Healthcare systems are challenging
the burden of chronic diseases by putting more em-
phasis on prevention, and by looking for new ways to re-
orient the provision of care in the light of the day-by-
day collected data. A paradigm shift in healthcare deliv-
ery is required to meet these needs [2]. Individuals
should be followed throughout the whole care process;
their self-management role and capabilities must be
clearly identified, together with the resources and ser-
vices delivered by the healthcare system in relation to
the stage of the disease.
Among chronic diseases, diabetes represents one of the
greatest health threats worldwide, with 425 million
people affected. The urbanization and rise of western
lifestyle are accelerating the diabetes epidemic. Ninety
percent of patients with diabetes have Type 2 Diabetes
(T2D). The disease can be asymptomatic, slowly evolving
in a first phase but then appearing with complications
even before its diagnosis [3, 4].
While there is a clinical consensus on how to manage
the disease through drug treatment, screening, self-man-
agement, and behavioral change, current challenges in-
volve novel patients’ stratification strategies and effective
case management, both at population and individual
levels. Clinical, social, and political coordinated actions,
in primary and secondary care, are required to prevent
or delay T2D onset and complications. Risk prediction
models could effectively contribute to support such
healthcare interventions and decision-making processes
[5]. However, despite the large number of models being de-
veloped and the increased interest in the clinical field, only
few ends up being used in the clinical practice. Further-
more, there is a lack of consensus and examples regarding
how to properly embed them into computerized Clinical
Decision Support Systems (CDSS) addressing proactive
search, risk stratification and case management [6–8].
In the most recent reviews about the effects of CDSS,
performed in 2005 [9], 2011 [10] and 2013[11] it was
shown that they are quite useful to improve healthcare
processes, their impact has been constantly improving and
consistent over the years, especially for diabetes manage-
ment, with an increased number of interventions in pri-
mary community settings and multiple practices. The lack
of solid explanations behind successes and failures has
been recognized, suggesting inclusion and analysis of
more dimensions, such as “system design, local context,
implementation strategy, costs, adverse outcomes, user
satisfaction, and impact on user workflow”.
In a more recent meta-analysis of qualitative studies,
Miller et al. tried to provide contextual knowledge and
possible explanations about variability of results and bar-
riers towards deployment of CDSS [12]: they found that
qualitative studies about CDSS are still scarce, and this
may explain the limited understanding of actual health-
care workflows. While most studies report on alert and
reminder systems, few are informing about interaction
designs, naturalistic decision making, diagnostic pattern
recognition, situation awareness and segments of the
healthcare environments. Interaction between CDSSs
and decision makers, aggregation of information to ex-
tract and present meaningful synthesis for clinical deci-
sions and on the understanding of human reasoning and
problem solving in real world settings should be further
researched. The need for increased collaboration among
social, behavioral, cognitive and computer scientists has
been identified as a critical element to understand the
main tasks, actions, and expectations of the different
healthcare professionals involved in the management of
chronic diseases.
Adopting human-centred design techniques can help
to maximize usability, identify design goals, understand
unmet needs and unsolved problems [13], and is central
for work domain analysis, design and evaluation of
health information system [14], as it allows understand-
ing the cognitive work performed by practitioners in dif-
ferent contexts, identifying usability problems and
reducing errors through task analysis, focus groups and
semi-structured interviews [15–18].
From a methodological perspective, the importance of
combining human centred design with system engineer-
ing and design life cycles have demonstrated to increase
reliability, compliance and safety of health information
systems [19]. However, a great number of health infor-
mation systems are not designed following human
centred design guidelines, resulting in low satisfaction,
acceptance and abandonment. These systems could be
improved by combining different disciplines, ranging
from computer to social and behavioural science [20].
Ethnographic techniques can be useful to understand
that barriers for effective use of CDSS are almost non-
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technological [21], analysing stakeholder groups allows
to understand that a CDSS may be misused or under-
used if their needs, knowledge and priorities are not
taken into account [22], is more and more relevant in
the decision making for the purchase of medical devices
and for health technology assessment [23], and can have
a negative or disruptive impact in practitioners routines
[24].
To sum up: designing tools that support healthcare
transformation for better control of chronic diseases,
such as T2D, requires a holistic approach.
In this study, we leveraged on holistic, evidence-based
frameworks and initiatives [25–28], to understand how
risk models for T2D should be embedded in a CDSS
and allow better management and coordination between
healthcare providers and decision makers.
The work has been performed in the context of the
MOSAIC (MOdels and Simulation techniques for dis-
covering dIAbetes influence faCtors) project, funded by
the European Commission. The consortium was com-
posed of European institutions and enterprises combin-
ing different expertise, such as medicine, epidemiology,
biomedical engineering, medical informatics, and med-
ical technology. The goal of the project was to develop
new computer models [29, 30], and implement them in
tools to support the detection and prediction of T2D on-
set and related complications, in different healthcare set-
tings (e.g. hospitals, clinical centres and health agencies).
We integrated computer models into DSSs for T2D
management, detection and prevention and studied how
end-users and stakeholders interacted with the system.
That is why, in the method section, we inform on how
different methodologies and techniques have been se-
lected and combined to gather perspectives from pro-
spective stakeholders and end-users, and to define of
contexts and scenarios of use. Our findings are pre-
sented in terms of user needs, implementation and
evaluation aspects, and then discussed with a special at-
tention on the cognitive and behavioural domains.
Methods
To perform our study we leveraged on a holistic and evi-
dence-based framework, the CeHRes Roadmap [28], built
on a participatory development approach, persuasive design
techniques and business modelling [31, 32] and be used by
the project management team (i.e.: the team involved in the
design, implementation and evaluation of the technology)
as an instrument through which stakeholders can debate to
clarify areas that “would otherwise remain unanswered, un-
clear, or unknown”, and in which “technology is not consid-
ered as a tool or end in itself, but as a catalyst for
innovation” [28]. The Roadmap consists of five sequential
and one iterative retrofitting phases (Contextual Inquiry,
Value Specification, Design, Operationalization, Summative
Evaluation, and Formative Evaluation); for each phase, a
list of main research questions, tasks and methods is
provided.
We used the roadmap to guide the design of our
methodology, organized in three main phases, as shown
in Fig. 1: User Needs, Implementation and Evaluation.
For each phase, the sequence (arrows) of use of the
methods (white rectangles) is represented, together with
the main intermediate (green boxes) and final (orange
boxes) outputs.
User needs
We first used the Running Lean Canavas, a business ori-
ented methodology to study new ideas and build suc-
cessful products [33], to understand and define from a
clinical, economical and customer perspective how vali-
dated predictive models for T2D might impact current
clinical practices. The most relevant output of this
method is a formal definition of the problem, objectives,
and solutions. Then, we carried out thematic focus
groups to determine and describe the key stakeholders,
as well as to identify and understand the healthcare im-
provements and to specify needs and requirements to be
covered [34, 35] from the clinical, scientific and socio-
economic perspective. To further study user needs and
transform them into a structured set of specified re-
quirements, the Analytic Hierarchic Process (AHP) was
used. AHP is a multi-dimensional, multi-level, and
multifactorial decision-making methodology that pro-
vides a framework for structuring a decision problem,
representing and quantifying its elements, and relating
those elements to the overall goals [36–39]. This method
has been already used in healthcare for user needs elicit-
ation and evaluation framework. Users of the AHP start
decomposing decision problems into a hierarchy to eas-
ily include sub-problems. Two experts for each sub-
problem are needed. Once the hierarchy is built, experts
evaluate its elements by the means of pairwise compari-
sons. Once evaluations are done, experts discuss and
comment the results generated, to gather insights and
transform them into requirements and guidance for the
development stage.
The output of this phase is a structured and balanced
description of user needs, values and attributes that can
be used as specifications for the implementation phase.
In our work we have used a web based online system,
the AHP-OS [40]. The questionnaires have been in-
cluded as Additional files 2, 3 and 4 to this manuscript.
Implementation
Once requirements were defined, the design process
started. In addition to traditional methodologies for soft-
ware development, the main ideas were drafted via use
cases description and functional specifications, which
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allowed to create and discuss mock-ups with the
intended end-users. Following up on these discussions,
the prototypes were refined from low-level mock-ups to
functional mock-ups. The functional mock-ups were
tested with Human Computer Interaction (HCI) experts
first and then with end-users in close to real life situa-
tions. Both were invited in several rounds to test
whether the mock-ups match usability standards, end-
user’s way of thinking and working. More in detail,
Heuristic Evaluation (HE) was used by HCI experts to
identify usability issues in the existing concepts and pro-
totypes, and to identify common usability issues before
performing tests with end-users. Evaluations were per-
formed by applying the 10 Nielsen Heuristics [41]. In
turn, the concept and the first functional prototypes
were refined. Then, Usability Testing was performed by
end-users to identify improvements in the software pro-
totypes. The usability levels were assessed through two
validated questionnaires, one to measure satisfaction as
perceived usability, the System Usability Scale (SUS)
[42], the other one to assess user experience, the Attrak-
diff [43], in line with the ISO9241.210 [44].
In the case of the SUS we have used the grading score
from Sauro and Lewis [45], ranging from F (unsatisfac-
tory) to A+ (absolutely satisfactory):
 Grade F (0–51.7)
 Grade D (51.8–62.6)
 Grade C– (62.7–64.9)
 Grade C (65.0–71.0)
 Grade C+ (71.1–72.5)
 Grade B– (72.6–74.0)
 Grade B (74.1–77.1)
 Grade B+ (77.2–78.8)
 Grade A– (78.9–80.7)
 Grade A (80.8–84.0)
 Grade A+ (84.1–100)
The output of this phase were the final prototypes,
ready to be used in the evaluation phase.
Evaluation
The main objective of this phase was to analyse the per-
formance of the system in terms of uptake and potential
impact. To assess the behaviours of end-users when
interacting with the prototype, the following methods
were adopted to analyse user interactions, needs and us-
ability aspects:
 Log files were used to understand user interaction,
collecting information about how real users were
performing routine actions using the developed
prototypes during their clinical practice. To facilitate
the analysis of log files, an identifier for each of the
actions, and for each of the situations or screens
accessed while using the tool, was created. Log4J
[46] and Log4Net [47] libraries were used.
 User Needs were re-assessed through focus groups,
this time to understand the impact of the designed
solution in the clinical practice.
 User satisfaction and experience were assessed
through the SUS and Attrakdiff questionnaires,
delivered at the end of the study. As suggested by
Borsci et al., in the case of solution 2.1 and 2.2, since
Fig. 1 Overall view of the methodology adopted, inspired by the CEHRES roadmap and organized in three main phases, user needs (left),
implementation (middle) and evaluation (right). For each phase, different methods (white rectangles) where used to get intermediate (green
shapes) and main result (orange shapes)
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they were used for enough time, the learnability
component has been also assessed [48, 49].
Characteristics of participants
Table 1 summarizes the characteristics of the involved
users (demographics, professional expertise and skills).
Ninety healthcare professionals were involved, between
four and seventeen in focus groups, and between four and
nine for the heuristic evaluation, usability tests and usabil-
ity questionnaires, in line with what suggested by Nielsen
to spot the most important usability problems [50].
Clinical focus group and Analytic Hierarchy Process
involved between six to eight individuals (at least two
per each domain). They were medical doctors, health-
care managers, nurses or other type of professionals in-
volved in T2D care (e.g. case managers, nutritionists).
Software developers, biomedical engineers, graphic de-
signers experienced in the adoption of human computer
interaction methodologies, were involved in the heuristic
evaluations. In the business focus group, most of them
were healthcare managers. In none of these evaluations
there was the need to have an informed consent or ap-
proval from ethical committee. While in focus groups
the average age is around 50 years with more than 20
years of experience, in the evaluation the medium age is
42 years with about 14 years of experience. The IT liter-
acy is medium or high for almost all the users, with
some exception with the clinical focus group for solution
2 and for the users involved in the evaluation phase.
Results
Results are presented for each one of the three phases.
User needs
Lean canvas
Domain experts were involved in approaching the prob-
lem from different perspectives (e.g.: technological, clin-
ical, epidemiological, industrial, etc.) until a consensus was
reached. They recognized that current diagnostic criteria
are biased on microvascular complications, missing to
identify early symptoms of the disease. Two types of DSS
were proposed:
 a DSS for T2D Screening, hereinafter also referred
as Solution 1, for detection and prediction of the
onset of the disease: a system to be built on top of
intelligent risk-scores based on probabilistic models
derived from dataset that, at present, are almost
available from clinical studies;
 a DSS for diagnosed T2D patients, hereinafter also
referred as Solution 2, making use of longitudinal
healthcare records to derive trends and patterns
through data mining techniques for better
characterization and prediction of complications:
two subsets of solutions were further identified, one,





Type of Expertise IT Literacy (Min 0, Max
3)
Design
Clinical Focus Group Solution 1 M = 4;F = 1 57 ± 8 30 ± 7 MD = 2, HCM = 2, N/O = 1 H = 3;M = 1;L = 1
Clinical Focus Group Solution 2 M = 5, F = 3 46 ± 14 17 ± 11 MD = 6, HCM = 1, GP = 1 H = 2;M = 3;L = 3
Clinical Focus Group Solution 1 and 2 M = 1;F = 3 50 ± 8 23 ± 12 MD = 3, HCM = 1, N/O = 0 H = 2;M = 2;L = 0
Scientific Focus Group M = 1;F = 3 55 ± 5 22 ± 5 MD = 2, HCM = 1, N/O = 1 H = 3;M = 1;L = 0
Business Focus Group M = 13;F = 4 46 ± 10 19 ± 10 MD = 0, HCM = 17, N/O =
1
H = 17;M = 0;L = 0
Analytic Hierarchy Process Solution 1 M = 2;F = 6 47 ± 9 20 ± 10 MD = 3, HCM = 3, N/O = 2 H = 1;M = 5;L = 0
Analytic Hierarchy Process Solution 2.1 M = 3;F = 3 54 ± 9 29 ± 10 MD = 2, HCM = 1, N/O = 3 H = 2;M = 6;L = 0
Analytic Hierarchy Process Solution 2.2 M = 2;F = 6 43 ± 12 17 ± 11 MD = 5, HCM = 3, N/O = 0 H = 0;M = 7;L = 1
Implementation
Heuristic Evaluations (Solution 1 and
2)
M = 2,F = 3 34 ± 4 8 ± 4 BE (4), GD (1), SWD (2) H = 5; M = 0;L = 0
Usability Test Solution 1 M = 3, F = 1 46 ± 13 14 ± 6 MD = 2, HCM = 1, N/O = 1 H = 2; M = 1; L = 1
Usability Test Solution 2 M = 1, F = 4 38 ± 10 13 ± 11 MD = 4, N/O = 1 H = 1; M = 3; L = 1
Evaluation
Solution 1 M = 1, F = 6 42 ± 9 14 ± 10 MD = 6, HCM = 1, N/O = 0 H = 3; M = 3; L = 1
Solution 2 M = 3, F = 6 41 ± 15 13 ± 12 MD = 6, HCM = 2, N/O = 1 H = 2; M = 5; L = 2
M Male, F Female, BE Biomedical engineer, GD Graphic designer, SWD SoftWare developer, MD Medical doctor, HCM Health care manager, GP General practitioner,
N/O Nurses or others; H High, M Medium, L Low
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CDSS for T2D Management (hereinafter also
referred as Solution 2.1), to be used at population
level among healthcare managers and their teams,
the other, CDSS for Follow-up visits (hereinafter also
referred as Solution 2.2), by practitioners during
individual visits. Solution 2 is described in [51].
Focus groups
The vision, objectives and high-level solutions were dis-
cussed with end-users and stakeholders, to derive user
needs, values and expectations. Two clinical focus groups
with healthcare practitioners from the Madrid regional
healthcare service, Spain, and from the private and public
healthcare system of the Pavia province, Italy, were carried
out to discuss Solution 1 and Solution 2 respectively. A
third focus group was carried out with healthcare profes-
sionals from the Valencia regional healthcare service,
Spain, to confirm the results of the previous ones. Add-
itionally, two scientific focus groups were held, as well as a
business focus group oriented to explore the market po-
tential. The full results are detailed in the Additional file 1.
Regarding Solution 1, experts agreed about the import-
ance to have tools that allow to exclude those persons that
are not at risk of developing the disease (i.e. false positives)
and therefore reduce the unnecessary activities. The CDSS
should be linked with existing registries and allow defin-
ition of lifestyle interventions to mitigate the detected
risks. Several participants expressed concerns about the
increased workload and additional costs caused by such
tools. Regarding Solution 2, pattern recognition and
trends should be used to give an overview about what is
happening in a health unit, to improve the efficiency of
the provided services and to identify gaps between clinical
guidelines and real practice. From a scientific perspective,
reluctance to use information from subjective assessments
to build the models (e.g. patient diaries) and about fixed
time for predictions was clearly expressed. Using medica-
tions patterns and Continuous Glucose Monitoring as
proxy for complications was considered as innovative and
promising approach.
Analytic hierarchy process
The creation of the hierarchy, already described in [52],
helped to redefine, categorize and structure the outputs
of the previous activities into a hierarchy of needs,
shown in Fig. 2, and ranked by experts for solution 1,
2.1 and 2.2, as a reference for discussions and compari-
son of the priorities and future directions to be taken for
the implementation, evaluation and exploitation of the
tools. Four main categories of needs, Improving Support
to Decision, Increasing Satisfaction, Efficiency and Access
of Healthcare delivery, were identified. Three groups of
end-users ranked needs for each solution, as shown in
Figs. 3 and 4, illustrating how the 1st level (categories of
needs) and 2nd level (needs) were rated.
As T2D screening and T2D management are largely fo-
cused on taking decisions related to risk-stratification
strategies and allocation of resources, one of the most
important need is the Support to Decision, while Effi-
ciency of Healthcare (HC) delivery is the most important
need to assist diabetes specialists or general practitioners
(GPs) during follow-up visits. The second most import-
ant category for Support during follow-up visits is related
with the impact on the daily routines of professionals,
Satisfaction of Healthcare (HC) Delivery, while this is
not the case for T2D Management, considered as the
least important category. Efficiency of Healthcare (HC)
Delivery is the third category for T2DScreening, while it
is the second for T2D Management. Access in Health-
care (HC) Delivery is the least important category for
T2D Management and Support during follow-up visits,
while it is more important (third category), in the case
of T2D Management.
About Solution 1, we can appreciate from Fig. 4 that
length of prediction horizon, uncertainty management,
usability and model performances are the most import-
ant needs. For Solution 2.1, model performances and un-
certainty managements are important, however cost-
efficient output and optimization of resources are the top
ones. In the case of Solution 2.2 there is a mix of needs
like Solution 1 and Solution 2.1. Usability is highly im-
portant for Solution 1 and Solution 2.2, while has a
lower level of importance for Solution 2.1. Tools Avail-
ability, multimodality, and compatibility with EHRs are
ranked as less important for Solution 1 and Solution 2.2,
and as medium important for Solution 2.2.
Implementation
Use cases (UCs) and functional specifications were de-
veloped together with the definition of low-level and
functional versions of the mock-ups.
In the case of T2D Screening, three main UCs were de-
fined: UC1.1-Risk Factors and Indicators to be adapted
to Public Health, to be used by local, national and re-
gional healthcare agencies, which usually have demo-
graphic information available to perform population
screening. UC1.2-Risk Factors and Indicators to be
adapted into ambulatory settings, to be used at individ-
ual level in primary care by GPs. UC1.3-Risk Factors and
Indicators to be adapted to citizens for personal use, in
this case to be used as a self-screening tool promoted by
healthcare systems, professional societies, or patient’s
organizations.
In the case of T2D care, the UC resembles what identi-
fied in the need phase: U2.1-Top-down analysis for deci-
sion makers, to be used by managers in primary care or
secondary care units as a drill down, business intelligence
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tool at a population level. UC2.2-Decision support for clini-
cians, in this case, trends and patterns should be mined at
individual level, using information available in a primary
or secondary care unit and support practitioners. More
details on the UCs are provided in the Additional file 1.
All the UCs were developed and tested with human com-
puter interaction experts and end-users. In the case of
UC1.3, it was decided to wait for final and full validation of
the predictive models before starting to implement it, as it
directly involves patients, and it is not included in this work.
During the implementation process, two iterative
rounds of development took place, resulting in a low-level
mock-up and functional mock-up respectively. The first
mock-up was evaluated through heuristic evaluation,
Fig. 2 Hierarchy of needs for the development of the MOSAIC Tools
Fig. 3 First Level of Needs evaluated by end-users of Solution 1 – TD2M Screening (n = 8), Solution 2.1 – T2D Management (n = 6) and Solution 2.2 -
Support during Follow-up visits (n = 6). It can be observed how the same needs (highlighted with the same color) have been ranked differently for
each solution
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while the second was also evaluated through usability tests
with real users (their profile is provided in Table 1).
The most relevant usability aspects emerged during
the first evaluation were related with the most common
usability errors (H1 - Visibility of system status, H2 -
Match between system and the real world and H7 -
Flexibility and efficiency of use). Experts identified the
importance of decomposing the process that the tool is
supporting into smaller steps, while giving them a clear
picture about the whole process, and where she/he is at
a given moment (e.g. by using breadcrumbs). They
also suggested to inform users on the expected event
upon clicking a certain button or link through clear
text labels, as icons may be not enough self-
explanatory.
During the second heuristic evaluation, common
mistakes were reduced, while usability errors related
to the healthcare process increased (H2 - Match
between system and the real world and H3 - User
control and freedom were the most frequent in this
case). The most important finding is that users want
assisted guidance about the steps needed to perform
screening or risk-stratifications and for this reason
they need clear description of tabs, filters and gener-
ated outputs. More details about this study have been
described in [51–53].
The needs identified during this phase were shared by
all the cases and include: the need to increase personal-
ized filtering and stratification functionalities, to provide
visualization options, to automatically build and send re-
ports, to include additional contextual information and
explanations, and to provide more aggregated and less
complex information.
Figures 5 and 6 summarize the results of the
Attrakdiff for Solution 1 and 2: our quality criterion
consisted in having the Confidence Interval of the
mean value not touching the scale’s middle score of
3. The results for Solution 1 are above the minimum
threshold, meaning that they are “not frustrating”
end-users. The overall SUS Score is about 61, corre-
sponding to the D grade. The main issues that were
pointed out regarded the need of a technical support
to be able to use the system, the lack of confidence
in using it, and the necessity to learn too many
things before being able to use the system. Consider-
ing that a score above 80.3 is needed in order to
have highly usable products, the usability of the
MOSAIC tools for Solution 1 has been perceived as
low by primary care and healthcare agency users.
As regards Solution 2.1, as shown in Fig. 6, only
the identity hedonic quality is statistically above 3. In
the case of Solution 2.2, the pragmatic quality, the
stimulation and identity hedonic qualities are statisti-
cally above 3, while the attractiveness is around the
value of 3.
As regards the perceived usability, the SUS score
was 81.5 ± 7.62 (86.25 ± 8.83 for 2.1 and 78.33 ± 6.29
for 2.2).
The most important problem in the case of Solution 2
were inconsistencies found while using the system. The
results of these tests lead to several and important
changes on the prototypes. Within Solution 1, filtering
options were added, while interactions and displayed
information were made clearer. A new functionality
to create reports for the users of the different Use
Cases was added.
Fig. 4 User Need priorities for Solution 1 - T2D Screening, Solution 2.1 - T2D management and Solution 2.2 - Support during Follow-up visits
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In the case of Solution 2 interactions with the users
were simplified by means of aggregated visualization fea-
tures: traffic lights were added, to capture the attention
of the care provider in case a negative trend exists (e.g.:
increased glycated haemoglobin (HbA1c) level, de-
creased adherence to drug, etc.).
Evaluation
Once the final prototype was ready, the solutions
were tested in two different healthcare settings.
Solution 1 was tested in the endocrinology depart-
ment of a public and reference centre for T2D, Hos-
pital La Fé, in Valencia, Spain. Solution 2 was
evaluated during a pre-post study in the Endocrin-
ology department of the Istituti Clinico Scientifici
Maugeri Hospital of Pavia (ICSM), Italy. The clinical
impact is not reported in this work: as we focus on
qualitative aspects, describing the most relevant infor-
mation about user reactions, behaviours and needs.
Results on clinical impact have been reported in [51].
Fig. 5 User Satisfaction levels (means and Confidence Interval) for Solution 1, assessed through the Attrakdiff questionnaire
Fig. 6 User Satisfaction level for Solution 2.1 (UC2) and 2.2 (UC3), assessed through the Attrakdiff questionnaire
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In both hospitals, the studies were discussed and ap-
proved by the Institutional review boards.
Solution 1 (T2D screening tools)
To perform a realistic evaluation of T2D screening tools,
we defined two Validation Cases, one for healthcare
agency settings (VC1) and another, organized in three
sub-scenarios, for clinical settings (VC2).
 VC1 – T2D Prediction Tool for Health Care
Managers, to predict how many patients are at risk
of developing T2D and eventually design
intervention strategies at regional level.
 VC2.S1 – T2D Prediction Tool for Clinicians, to
predict how many patients in a healthcare unit are
at risk of developing T2D and design interventions
at unit level.
 VC2.S2 – Case Titration, to validate the system
response. This tool is used by a doctor or by a
nurse, who has a list of patients at risk and its goal
is to help users to validate the risk of T2D suggested
by the system.
 VC2.S3 – T2D Detection and Parameter Estimation
Tool, estimating the risk to develop T2D within the
next 12 years for each patient, based on the
automatic estimation performed on the values of
clinical and demographic variables that have no
value and based on the estimation of oral glucose
tolerance test and high density lipoprotein
cholesterol.
Usage of the tool through log file analysis
The tools have been used for 2 weeks in May 2016.
Eleven professionals used the tools (Table 1); statistics
about number and duration of sessions as extracted
from the system log files are shown in Table 2: the tools
were used between two and three professional per day,
for about half an hour, with six patients evaluated per
user, ten patients per day.
The most accessed case was the one related to T2D
Detection and Parameter Estimation Tool (45% of the
times), followed by Case Titration (34%), T2D Prediction
Tool for Clinicians (16%) and T2D Prediction Tool for
Managers (5%).
Overall feedback from focus groups
Solution 1 represents a change in terms of organizational
and procedural aspects as it triggers an active risk strati-
fication of T2D (in primary care, secondary care or
healthcare agencies). The action required to introduce
an effective risk stratification tools for T2D regards an
active collaboration with the healthcare organizations
available to implement this innovation. This involves
generating data warehouses specific for this purpose
(upon a process of data pooling and quality checks) and
the training of healthcare professionals. The personnel
involved in the evaluation has provided feedback on how
to improve some specific aspects, such as: body mass
index (BMI) categories should meet the WHO recom-
mendations; the decision-making process for risk predic-
tions should be based on the comparisons with what
detected by professionals; recommendations should be
displayed in checkboxes, so to better select them de-
pending on the risk estimation and the imputed vari-
ables; more filtering options should be included (e.g.
erectile dysfunction).
Usability and user experience via questionnaires
User satisfaction levels, evaluated through the Attrakdiff
questionnaires, were found above the minimum thresh-
old of 3, meaning “almost very good” for all the 4 subor-
dinate constructs (pragmatic quality, stimulation and
identification, and attractiveness), as shown in Fig. 7.
Perceived usability was 55.36: this value according to
Sauro&Lewis can be interpreted as a grade of a D. The
main issues pointed out in this case regarded the need
of a technical person to be able to use the system, the
perception of the system as cumbersome and the neces-
sity to learn too many things before using the system.
We can conclude that MOSAIC T2D tools for Solution
1 have good levels of user experience but low levels of per-
ceived usability; they are introducing a breaking and dis-
ruptive routine and therefore more work and efforts in
terms of user training, and set up of organizational and
procedural measures.
Solution 2 (evaluation of T2D management tools)
The tools were evaluated at Istituti Clinico Scientifici
Maugeri Hospital of Pavia (ICSM), Italy, for Solution 2.1
(population management) and 2.2 (clinical decision
Table 2 Distribution of sessions (number, duration, number of patients per day and per session)
Mean SD Min Max
Number of users per day 2.5 1.6432 1 4
Duration of sessions (min) 26.16 13.7150 0.25 (≈15 seg) 45.93
Number of patients evaluated per user 6.25 4.9749 1 15
Number of patients evaluated per day 10.7143 12.1890 0 26
Number of sessions per doctor (user) 1.8182 1.1677 1 5
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support for single patients during visits). Solution 2.1
and 2.2 have different settings, employments and users.
The implemented evaluation strategies, while following
the general proposed schema, required specific adapta-
tions. In the Solution 2.1 the focus was to evaluate the
introduction of a new process that was not possible earl-
ier for diabetes patient management. In the Solution 2.2,
the evaluation of the impact was performed both during
clinical activities while monitoring clinicians using the
tool and by performing usability testing. In the following,
we illustrate the results of the evaluation activities using
the log files of the system, focus groups and
questionnaires.
Usage of the tool through log file analysis
The prototype was tested in a real clinical and health care
environment for a period of 55 days (January – April
2016). Once having been trained about the system func-
tionalities, clinicians were asked to use the tool during
their daily activities, for the management of the ward and
during follow-up visits. A total of 305 sessions were re-
corded (being a session defined as the continuous time
interval that a user has used the tool, considering as the
start event the access to the tool, and as the end event the
last interaction with the tool, defined as the latest inter-
action before a non-continuous use of the application took
place). The results show that Solution 2.2 (patient man-
agement during visits) were more extensively used than
solution 2.1 (population managements). The 55% of the
accesses to the system were related to Solution 2.2. Table 3
shows statistics regarding the number of sessions per day,
their duration, and number of patients visited during
follow up visits at the hospital, assessed through the evalu-
ation of Solution 2.2.
We collected and studied the number of times users
accessed the main menu options and the main modules,
and for each module the number of times they accessed
specific functionalities. Specifically, the implemented
final prototype of Solution 2.2 is structured in three
main screens representing risk factors and their evolu-
tion in time, clinical variables time series and drug pur-
chase patterns. The access distribution was uniformly
distributed among three screens: 30% for the risk factor
screen, 32% for the drug exposure, and 38% for the clin-
ical variables screen.
Overall feedback from focus groups
We performed two evaluation sessions involving three
clinicians and one healthcare policy maker. During these
sessions, clinicians were asked to use solution 2.1 and
compare snapshots of the MOSAIC population across
different time periods. We considered the population at
the beginning and at the end of the validation study
(January 2016 and April 2016). The main clinical com-
ments on the center population regarded:
 The usefulness of the tool to inspect specific clinical
questions. Participants highlighted the importance
to identify sub cohorts of patients who experienced
a specific acute event to inspect possible
noncompliance to guidelines.
 The possibility to analyze disease progression
through longitudinal data representation as a
function of hospitalizations and disease uptake. They
Fig. 7 User Satisfaction levels (minimum acceptable threshold is 3)
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were able to cluster specific groups of subjects while
assessing disease complexity, they found this
functionality crucial to understand the treated
population.
 The comparison of the center population at two
different time points. A comparison of the
population between the start and the end of the
validation period highlighted a significant increase in
the number of patients with high cardiovascular risk.
This result stimulated clinicians to in-depth inspect
how the cardiovascular risk evolved in time, to
understand which groups of patients reached the
maximum risk level, and to formulate hypotheses on
the detected situation.
Several useful comments were also made regarding
the functionalities of the system. Users were inter-
ested to (i) refine tuning features for customized fil-
tering and temporal analyses functionalities, (ii)
personalize the display of the results and (iii) add fur-
ther information and statistics to answer specific re-
search questions on the population.
Usability and user experience via questionnaires
In both solutions the user experience is “very good”, as
it is above 3 and almost above 3.5 for all the dimensions,
about 0.5 better than the previous evaluations, as shown
in Fig. 8.
Similar results are observed also for the SUS scale.
The overall SUS Score is 79.32, corresponding to the
grade of B. System learnability was scored as 3 (STD 1.2
for solution 2.1 and 0,8 for 2.2).
To conclude, the usability and learnability scores for
Solution 2 are quite good. However, it was not possible
to make a 3rd round of developments, following the us-
ability recommendations provided after the usability
tests and this could explain the slightly reduced score
from the tests (where an 81.5 score was obtained) to the
final evaluations (79.3).
Discussion
In this work we have presented a holistic approach to
design, implement and evaluate IT solutions to tackle
the epidemics of T2D. This approach, applied in the
context of the MOSAIC project, was based on the
Table 3 Distribution of sessions (number, duration, number of patients per day and per session)
Mean SD Min Max
Number of sessions per day 5.3509 2.7870 1 14
Duration of sessions (min) 47.4314 88.9975 0 (22 s) 465.8000 (≈ 8 h)
Number of patients per session 1.5574 1.3780 0 9
Number of patients per day 8.3333 4.5878 1 28
Fig. 8 Results of the AttrakDiff Questionnaire for Solution 2.1 (UC2) and 2.2 (UC3)
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CeHRes Roadmap, which has been further elaborated to
precisely define the sequence and combination of actions
and methods to be executed at each step.
This mixed method approach allowed to acquire all
the necessary information during a short period of time,
thus optimally supporting the development process.
Similarly to relevant literature in cognitive informatics
[13], we have focused on diverse stakeholders to catch
different perspectives, relied on multiple methods to
make them more reliable and discovered elements, prop-
erties and perspectives which are more difficult to ex-
tract with traditional methods: If, from the functional
and technical side, the requirements can be gathered
through traditional software engineering techniques (like
Use Cases development), other techniques coming from
human and social sciences were adopted to meet the
needs of end-users. It is important to perform usability
tests before the final validation, in order not to com-
promise its success. If the prototype turned out to be
not usable enough for many users, the whole evaluation
would be jeopardized. The process that led to the devel-
opment and implementation of the system prototype in-
volved end-users and stakeholders in the whole analysis
through multiple and small tests as recommended by
Nielsen [50].
Given the multidisciplinary nature of T2D care and its
challenges, and the need to find a balance on how much
effort can be dedicated to the reiteration of the develop-
ment phases, the holistic and flexible nature of the
CEHRES roadmap was useful. Holistic means that sys-
tem designers, clinicians, biomedical engineers, but also
health economists and business developers, should actu-
ate synergic strategies to develop integrated solutions
and avoid isolated activities. Since a holistic approach
can be counterproductive if not accompanied by a re-
dundant strategy, multiple and repeated tests are needed
before drawing a consolidated “holistic” conclusion,
whether it is on user needs, implementation or evalu-
ation aspects. We think that our approach is quite
complete and comprehensive: from a human centered
design perspective, it allowed identifying topics and col-
lecting insights to better understand the barriers towards
CDSS implementations, letting users to achieve their
goals, as identified by [15–18].
To our knowledge this is one of the first works fo-
cused on understanding user needs, behaviours and ex-
pectations and corresponding requirements for CDSS
built on top of predictive models and data mining tech-
niques for chronic diseases. For this reason, we have re-
ported results in the three main phases, User Needs,
Implementation and Evaluation.
Regarding the User Needs phase, we have highlighted the
importance of conducting multiple focus groups to catch
different perspectives before drawing a list of consolidated
user needs and values. We have used Lean Canvas to
formalize the problem, objectives and solutions, and to
identify customer segments. User needs were put in hier-
archical order thanks to the AHP. Similarly to [54] the
identification of value at early stage with has been consid-
ered as vital to drive the design of our solutions and have
evidence-informed value proposition. However, in our case,
the literature review was replaced by a “Scientific focus
group”, where experts helped us to align our innovations to
current practice and guidelines.
We have found that prediction models for the onset of
T2D can be introduced in the clinical practice by under-
standing the data that they can work with: these models
can be built, trained, and validated on data coming from
clinical studies, as the current healthcare systems are not
(still) producing reliable and longitudinal information on
people at risk of T2D. On the other hand, information
on people already diagnosed with T2D does exist and it
is produced by healthcare information systems, but
mainly for administrative and financial purposes: the
challenge is how to pool and aggregate information that
can be relevant for clinical practitioners. These findings
allowed us to focus on the definition of operative solu-
tions and objectives around these two main activities:
Solution 1, using predictive models built on top of exist-
ing clinical studies on T2D onset. Solution 2, using data
mining techniques on top of existing longitudinal elec-
tronic health records data. The execution of multiple
focus groups helped us to gather and consolidate user
needs for each solution. In some cases, the information
collected was even contradictory: for instance, in Solu-
tion 1, some end-users wanted the system to focus ex-
clusively on identifying False Positives, others on True
Negatives, others were even scared about a tool that
could support in finding new cases of T2D. This high-
lights the perception that the discovery and management
of new cases for T2D could introduce a novel routine
(that was referred to as active search) in the existing
healthcare system.
Within Solution 2, we faced a different situation: while
guidelines and recommended actions on how to manage
T2D are available, the challenge is to deliver reliable and
meaningful information to daily practitioners and man-
agers. During the first phase, we realized that the offer
related to Solution 2 should be split into two sub-solu-
tions, the first giving support at a population level (Solu-
tion 2.1) and the second at an individual level (Solution
2.2). Once the problem was de-structured and analysed
as different sub-problems, we used AHP to recompose
the puzzle and have a consolidated view of user needs,
objectives and problem. We ranked priorities for all the
solutions, and we found that in some cases solution 1
and solution 2.1 had similar priorities, since they both
deal with support on risk-stratification decisions.
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Solution 1 and solution 2.2 have in common the import-
ance of not introducing a negative impact on the daily
activities of health care professionals. The user satisfac-
tion dimension is extremely important: in the first case
because we are introducing an “extra” activity (active
search of new T2D patients) within the clinical work-
flow, in the second because we should reduce the bur-
den of GPs and specialists in following up a multitude of
T2D patients. Furthermore, we noticed that HC man-
agers give more importance to have tools available every
time and everywhere, while professionals involved in
T2D management and screening do prefer an easy to
use solution.
All the previous findings were used to develop our so-
lutions during the implementation phase. We defined 3
UCs for Solution 1, being performed at multiple levels
(e.g.: primary and secondary care, healthcare agencies,
citizens, etc.), while Solutions 2.1 and 2.2 have been
mapped to 2 UCs, focused on primary and secondary
care settings. Lean Canvas helped us to formalize use
cases, beneficiaries and end-users. Two rounds of HE
allowed us to reduce common usability errors and focus
on improving usability aspects related to the healthcare
process we are introducing with our tools. Even with a
well-defined development plan, IT experts can uncon-
sciously underestimate the importance of providing clear
and continuous guidance to the end-user of the tool
during each moment of the interaction. The improve-
ment of these aspects prior to the conduction of usabil-
ity tests allowed us to find further improvements that
were more related with their real needs. In the case of
solution 1, we could clearly identify and design specific
moments that are relevant to the active search for T2D:
gathering structured input information, running ad hoc
risk models, interpreting their results and take actions
according to the predicted scenarios. We could under-
stand that the configuration of the tools can be different
for each healthcare setting. For example, a public health
agency has less information that is usually provided at
population level. Models in this case should work also
when information is not continuously available, and the
most relevant action is the connection with primary and
secondary care centres that can continue the active
search in their settings. In the case of solution 2, even
though we could provide users with suitable filtering op-
tions and valuable information, they were still not con-
vinced about the effective introduction of our tool. For
this reason, for solution 2.2, we introduced attractive vis-
ual analytics (using the traffic lights representation) to
catch the attention of end-users and make them focus
on specific parameters. For solution 2.1, we understood
that we needed more efforts to further simplify, aggre-
gate, and synchronize the information coming from dif-
ferent sources (e.g. drug intake patterns, appearance of
complications, diet levels, etc.), and we focused on pro-
viding end-users with a way to dynamically formulate
clinical questions through the tool.
About the evaluation phase, the first finding is about
the difference of studies that were chosen to evaluate the
two solutions. Given the innovative aspects associated to
Solution 1, it is difficult to find centres that have avail-
able and reliable information to screen for T2D, as well
as human and financial resources to perform active
searching. For this reason, the evaluation study had an
exploratory nature, to understand the reactions of end-
users to this kind of innovative software solution. We
thus introduced Validation Cases to simulate actions
and interactions between users and units. In this phase,
the most important feedback related with T2D Screen-
ing is that we were introducing a new process, rather
than facilitating or supporting the existing practice. This
means that users need to learn and understand how this
tool can be related with their daily activities. The result-
ing good levels of user experience versus the not good
level of usability suggest that they perceived the good
potentials of the tool, but they are worried about the
complexity it adds to their working routines.
In the case of Solution 2, one of the most interesting re-
sults is related to the interest of end-users in the possibil-
ity of using Solution 2.1 functionalities to answer specific
clinical questions, related either to specific conditions (e.g.
myocardial infarction, poly-medicated patients) or to the
evolution of the disease in terms of complexity, which
might be relevant to evaluate the specific features of the
care center. Starting from a selected population, it is pos-
sible drilling-down to more detailed information up to in-
dividual cases, using Solution 2.2.
Even if end-users expressed the need of more
personalization and filtering options, in both cases the
usability and the user experience are all above the ac-
ceptable thresholds.
The proposed holistic approach is aimed at helping
IT innovators in providing solutions for the multiple
end-users, stakeholders and healthcare units that
should be involved in the continuum of care, early
detection and risk stratification of prevalent chronic
diseases such as T2D.
Our study has several limitations: first, we were not
able to prospectively evaluate the final prototype of solu-
tion 1 in primary care settings and healthcare agencies;
to minimize this limitation we involved these types of
users in single sessions of usability tests. Second, we
were not able to finalize the developments of the final
prototype for Solution 2; this would have allowed us to
have even better usability score. These limitations, which
are typical of interdisciplinary and international research
projects, recall real life situations, when the project man-
agement team must take decisions that may positively
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affect some aspects and negatively influence others. It is
important to take consensual decisions and give prefer-
ence to multiple, multifaceted, stepwise short but fo-
cused evaluations, rather than wide but dispersed ones.
Conclusions
In this study, a holistic approach was adopted and con-
textualized to design a system able to turn computerized
modelling techniques into IT tools that support decision
makers in T2D. Starting from the CeHRes roadmap, we
have defined a methodology that details the sequence
and composition of multidisciplinary methods (Lean
Canvas, Multiple Focus Groups, Heuristic Evaluation,
Usability Testing, User Interaction analysis) and is orga-
nized in three phases (user needs, implementation and
evaluation). These phases are all equally important to
gather information and to understand end-user needs,
their behaviours, reactions and expectations with the
technological solution that is iteratively provided to
them. In future works we will focus on the results of the
evaluation, highlighting the clinical impact of the MO-
SAIC solutions. Our approach was useful to clarify
which are the future research and innovation directions
to eventually translate our findings to real practice, with
the final aim to innovate healthcare management with
holistic, long term and comprehensive strategies.
Additional files
Additional file 1: Detailed information on Lean Canvas, Focus Groups
and Use Cases. (DOCX 20 kb)
Additional file 2: AHP Questionnaire - Solution 1. (DOCX 836 kb)
Additional file 3: AHP Questionnaire - Solution 2.1. (DOCX 836 kb)
Additional file 4: AHP Questionnaire - Solution 2.2. (DOCX 836 kb)
Abbreviations
AHP: Analytic Hierarchic Process; BMI: Body mass index; CDSS: Clinical
Decision Support Systems; CGM: Continuous Glucose Monitoring;
DSS: Decision Support Systems; EHR: Electronic health record; GP: General
practitioner; HC: Healthcare; HCI: Human Computer Interaction; HE: Heuristic
Evaluation; IT: Information Technology; MOSAIC: MOdels and Simulation
techniques for discovering dIAbetes influence faCtors; NHS: National Health
Service; SUS: System Usability Scale; T2D: Type 2 Diabetes; UC: Use case;
UCs: Use cases; VC: Validation Case; WHO: World Health Organization
Acknowledgements
The authors wish to express sincere gratitude to all the partners of the
MOSAIC project that made possible the realization of all the activities. A
special thank goes to end-users and stakeholders that participated to the
focus groups, interim and final evaluations.
Authors’ contributions
GF has designed the study and organized the conduction of all the
experiments, as well as contributed to the overall background, methodology
and discussion of the manuscript. LH and JC have executed and reported
results of all the experiments and contributed to the methodology section.
AM, AF, MO, RG, VT, JM designed and executed the evaluation study,
coordinated the execution of focus groups and usability tests related with
solution 1. AD, LS and KZ designed and executed the evaluation study,
coordinated the execution of focus groups and usability tests related with
solution 2. LG, RG, LC, JF have contributed and revised the clinical and
scientific information related with T2D diagnosis and management. JP, LM
and JV provided contribution related with the clinical and business focus
groups. KN, CC, RB and MTA have contributed to the substantial revision of
the manuscript. All authors read and approved the final manuscript.
Funding
The research leading to these results has received funding from the
European Commission under the European Union’s Seventh Framework
Programme (FP7/2007–2013) grant agreement n° 600914.
Availability of data and materials
The datasets used and/or analysed during the current study are available
from the corresponding author on reasonable request.
Ethics approval and consent to participate
All participants of focus groups consented to study participation and
audio-recording via written form. The studies described in the evaluation activities
were approved by the biomedical research ethics committee of the University




Lucia Sacchi is an Editorial Board Member for BMC Medical Informatics and
Decision Making. All the authors declare that they have no competing
interests.
Author details
1Universidad Politécnica de Madrid, Madrid, Spain. 2University of Manchester,
Manchester, UK. 3University of Pavia, Pavia, Italy. 4Universidad Politécnica de
Valencia, Valencia, Spain. 5Medtronic Ibérica, Madrid, Spain. 6University of
Padova, Padua, Italy. 7Asociación Española para el Desarrollo de la
Epidemiología Clínica, Madrid, Spain. 8National Technical University of
Athens, Athens, Greece. 9Lund University Diabetes Centre, Malmö, Sweden.
10Istituti Clinico Scientifici Maugeri Hospital of Pavia, Pavia, Italy. 11Hospital La
Fe, Valencia, Spain.
Received: 11 September 2018 Accepted: 2 August 2019
References
1. World Health Statistics 2018, Monitoring health for the SDGs, World Health
Organization. Available at: https://www.who.int/gho/publications/world_
health_statistics/en/, last Accessed 09 Aug 2019.
2. Kane R, Priester R, Totten A. Meeting the challenge of chronic illness.
Baltimore: The Johns Hopkins University Press; 2005.
3. Colagiuri, S., Kent, J., Kainu, T., Sutherland, S., Vuik, S. Rising to the challenge:
preventing and managing type 2 diabetes, report of the WISH diabetes
forum. 2015. Available from: http://www.wish.org.qa/wp-content/uploads/.../
WISH_Diabetes_Forum_08.01.15_WEB-1.pdf. Accessed 09 Aug 2019.
4. IDFD Atlas. 2017. Available from: http://www.diabetesatlas.org/resources/201
7-atlas.html. Accessed 11 Feb 2018.
5. American Diabetes Association Consensus Panel. Guidelines for
computer modeling of diabetes and its complications. Diabetes Care.
2004;27(9):2262–5.
6. Noble D, Mathur R, Dent T, Meads C, Greenhalgh T. Risk models and scores
for type 2 diabetes: systematic review. BMJ. 2011;343:d7163.
7. Abbasi A, Peelen LM, Corpeleijn E, van der Schouw YT, Stolk RP, Spijkerman
AM, et al. Prediction models for risk of developing type 2 diabetes:
systematic literature search and independent external validation study. BMJ.
2012;345:e5900.
8. Zarkogianni K, Litsa E, Mitsis K, Wu P, Kaddi CD, Cheng C, Wang MD, Nikita
KS. A review of emerging technologies for the management of diabetes
mellitus. IEEE Trans Biomed Eng. 2015;62(12):2735–49.
9. Garg AX, Adhikari NK, McDonald H, Rosas-Arellano M, Devereaux PJ, Beyene
J, Sam J, Haynes RB. Effects of computerized clinical decision support
systems on practitioner performance and patient outcomes: a systematic
review. JAMA. 2005;293(10):1223–38.
Fico et al. BMC Medical Informatics and Decision Making          (2019) 19:163 Page 15 of 16
10. Roshanov PS, et al. Computerized clinical decision support systems for
chronic disease management: a decision-maker-researcher partnership
systematic review. Implement Sc. 2011;6(1):92.
11. Roshanov PS, et al. Features of effective computerised clinical decision
support systems: meta-regression of 162 randomised trials. BMJ. 2013;
346:f657.
12. Miller A, Moon B, Anders S, Walden R, Brown S, Montella D. Integrating
computerized clinical decision support systems into clinical work: a meta-
synthesis of qualitative research. Int J Med Inform. 2015;84(12):1009–18.
13. Patel VL, Kannampallil TG. Cognitive informatics in biomedicine and
healthcare. J Biomed Inform. 2015;53:3–14.
14. Zhang J. Human-centered computing in health information systems part 1:
analysis and design. J Biomed Inform. 2005;38(1):1–3.
15. Rinkus S, Walji M, Johnson-Throop KA, Malin M, Turley JP, Smith JW, Zhang
J. Human-centered design of a distributed knowledge management system.
J Biomed Inform. 2005;38:4–17.
16. Nemeth CP, Nunnally M, O’Connor M, Klock PA, Cook R. Getting to the
point: developing IT for the sharp end of healthcare. J Biomed Inform. 2005;
38:18–25.
17. Xiao Y. Artifacts and collaborative work in healthcare: methodological,
theoretical and technological implications of the tangible. J Biomed Inform.
2005;38:26–33.
18. Malhotra S, Laxmisan A, Keselman A, Zhang J, Patel VL. Designing the
design phase of critical care devices: a cognitive approach. J Biomed
Inform. 2005;38:34–50.
19. Samaras GM, Horst RL. A systems engineering perspective on the
human-centered design of health information systems. J Biomed
Inform. 2005;38:61–74.
20. Johnson CM, Johnson TR, Zhang J. A user-centered framework for
redesigning health care interfaces. J Biomed Inform. 2005;38:75–87.
21. Patterson ES, Boebbeling BN, Fung CH, Militello L, Anders S, Asch SM.
Identifying barriers to the effective use of clinical reminders: bootstrapping
multiple methods. J Biomed Inform. 2005;38:189–99.
22. Laxmisan A, Malhotra S, Keselman A, Johnson TR, Patel VL. Decisions about
critical events in device-related scenarios as a function of expertise. J
Biomed Inform. 2005;38:200–12.
23. Ginsburg GE. Human factors engineering: a tool for medical device
evaluation in hospital procurement decision-making. J Biomed Inform.
2005;38:213–9.
24. Reddy M, McDonald DW, Pratt W, Shabot MM. Technology, work, and
information flows: lessons from the implementation of a wireless alert
pager system. J Biomed Inform. 2005;38:229–38.
25. Despont-Gros C, Mueller H, Lovis C. Evaluating user interactions with clinical
information systems: a model based on human–computer interaction
models. J Biomed Inform. 2005;38:244–55.
26. World Health Organization, 2009. Practical guidance for scaling up health
service innovations.
27. European Commission, 2015. European scaling up strategy on active and
healthy ageing.
28. van Gemert-Pijnen JE, Nijland N, van Limburg M, Ossebaard HC, Kelders SM,
Eysenbach G, Seydel ER. A holistic framework to improve the uptake and
impact of eHealth technologies. J Med Internet Res. 2011;13(4):e111.
29. Sacchi L, Dagliati A, Segagni D, Leporati P, Chiovato L, Bellazzi R. Improving
risk-stratification of diabetes complications using temporal data mining. In:
2015 37th annual international conference of the IEEE Engineering in
Medicine and Biology Society (EMBC). United States: IEEE; 2015. p. 2131–4.
30. Sambo F, Di Camillo B, Franzin A, Facchinetti A, Hakaste L, Kravic J, Fico G,
et al. A Bayesian Network analysis of the probabilistic relations between risk
factors in the predisposition to type 2 diabetes. In: 2015 37th annual
international conference of the IEEE Engineering in Medicine and Biology
Society (EMBC). United States: IEEE; 2015. p. 2119–22.
31. Van Velsen L, van Gemert-Pijnen L, Nijland N, Beaujean D, Van
Steenbergen J. Personas: the linking pin in holistic design for eHealth.
proc. eTELEMED; 2012.
32. Van Velsen L, Wentzel J, Van Gemert-Pijnen JE. Designing eHealth that
matters via a multidisciplinary requirements development approach. JMIR
Res Protoc. 2013;2(1):e21.
33. Maurya A. Running lean: iterate from plan A to a plan that works. United
States: O’Reilly Media, Inc.; 2012.
34. Wentzel J, Van Limburg M, Karreman J, Hendrix R, Van Gemert-Pijnen L. Co-
creation with stakeholders: a Web 2.0 Antibiotic Stewardship Program.
Proceedings of The Fourth International Conference on eHealth,
Telemedicine, and Social Medicine: January 30, 2012 to February 4, 2012;
Valencia. 2012:196–202.
35. Morgan DL. Focus groups as qualitative research. Thousand Oaks: Sage;
1997.
36. Saaty T. How to structure and make choices in complex problems. Hum
Syst Manag. 1982;3:255–61.
37. Saaty TL. A scaling method for priorities in hierarchical structures. J Math
Psychol. 1977;15:234–81.
38. Pecchia L, Bath PA, Pendleton N, Bracale M: Web-based system for assessing
risk factors for falls in community-dwelling elderly people using the analytic
hierarchy process. International Journal of the Analytic Hierarchy Process.
2010;2(2):135–57.
39. Fico G, Gaeta E, Arredondo MT, Pecchia L. Analytic hierarchy process to
define the most important factors and related technologies for
empowering elderly people in taking an active role in their health. J Med
Syst. 2015;39(9):1–7.
40. Goepel KD. Implementation of an online software tool for the Analytic
Hierarchy Process (AHP-OS). Int J Anal Hierarchy Process. 2018;10(3):469–87.
https://doi.org/10.13033/ijahp.v10i3.590.
41. Nielsen J. Ten usability heuristics. United States: Nielsen Norman Group;
2005.
42. Brooke J. SUS-A quick and dirty usability scale. Usability Eval Ind. 1996;
189(194):4–7.
43. Hassenzahl M, Burmester M, Koller F. AttrakDiff: Ein Fragebogen zur
Messung wahrgenommener hedonischer und pragmatischer Qualität. In:
Mensch & computer. Germany: Vieweg+ Teubner Verlag; 2003, 2003. p.
187–96.
44. International Organization for Standardization. Ergonomics of human-
system interaction: part 210: human-centred design for interactive
systems. United States: ISO; 2010.
45. Sauro J, Lewis JR. Quantifying the user experience: practical statistics for
user research. Burlington: Morgan Kaufmann; 2012.
46. Gülcü C. The complete log4j manual. QOS. ch; 2003.
47. Nantz B. Open source. NET development: programming with NAnt, NUnit,
NDoc, and More. United States: Addison-Wesley Professional; 2004.
48. Borsci S, Federici S, Lauriola M. On the dimensionality of the system
usability scale: a test of alternative measurement models. Cogn Process.
2009;10(3):193–7.
49. Borsci S, Federici S, Bacci S, Gnaldi M, Bartolucci F. Assessing user
satisfaction in the era of user experience: comparison of the SUS, UMUX,
and UMUX-LITE as a function of product experience. Int J Hum Comput
Interact. 2015;31(8):484–95.
50. Nielsen J, Landauer TK. A mathematical model of the finding of usability
problems. In Proceedings of the INTERACT'93 and CHI'93 conference on
Human factors in computing systems. 1993. pp. 206–13. ACM.
51. Dagliati A, Sacchi L, Tibollo V, Cogni G, Teliti M, Martinez-Millana A, et
al. A dashboard-based system for supporting diabetes care. J Am Med
Inform Assoc. 2018;25(5):538–47.
52. Fico G, et al. User requirements for incorporating diabetes modeling
techniques in disease management tools. In: 6th European conference of
the international federation for medical and biological engineering.
Switzerland: Springer International Publishing; 2015.
53. Cancela J, Hernandez L, Fico G, Waldmeyer MTA. Heuristic evaluation of a
toolset for type 2 diabetes mellitus management. In: XIV Mediterranean
conference on medical and biological engineering and computing.
Switzerland: Springer International Publishing; 2016, 2016. p. 982–7.
54. Borsci S, Uchegbu I, Buckle P, Ni Z, Walne S, Hanna GB. Designing medical
technology for resilience: integrating health economics and human factors
approaches. Expert Rev Med Devices. 2018;15(1):15–26.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Fico et al. BMC Medical Informatics and Decision Making          (2019) 19:163 Page 16 of 16
